Cavernous sinus thrombosis and meningitis from community-acquired methicillin-resistant Staphylococcus aureus infection

Internal Medicine Journal

Volumn 38, Issue 4, 2008, Pages 283-287

  Munckhof, W J ^a,b   Krishnan, A ^a   Kruger, P ^a   Looke, D ^a,b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cavernous sinus thrombosis; Community acquired infection; Meningitis; Methicillin resistance; Staphylococcus aureus

Indexed keywords

CEFTRIAXONE; CLINDAMYCIN; COTRIMOXAZOLE; ENOXAPARIN; ERYTHROMYCIN; GENTAMICIN; HEPARIN; LINEZOLID; PANTON VALENTINE LEUKOCIDIN; PENICILLIN BINDING PROTEIN 2A; RIFAMPICIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL MENINGITIS; CASE REPORT; CAVERNOUS SINUS THROMBOSIS; CEREBROSPINAL FLUID EXAMINATION; CEREBROSPINAL FLUID LEVEL; CLINICAL FEATURE; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG FEVER; DRUG MEGADOSE; GENOTYPE; HOSPITAL DISCHARGE; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; MULTILOCUS SEQUENCE TYPING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHLEBOGRAPHY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STAPHYLOCOCCUS INFECTION; THROMBOGENESIS; TREATMENT OUTCOME;

ADULT; CAVERNOUS SINUS THROMBOSIS; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; MALE; MENINGITIS, BACTERIAL; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 41549146381     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2008.01650.x     Document Type: Article

References (20)

1. Vandenesch F, Naimi T, Enright MC, Ling G, Nimmo GR, Hefferran H et al. Community-acquired methicillin resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003 9 : 978 84.
2. Peleg AY, Munckhof WJ, Kleinschmidt SL, Stephens AJ, Huygens F. Life-threatening community-acquired methicillin-resistant Staphylococcus aureus infection in Australia. Eur J Clin Microbiol Infect Dis 2005 24 : 384 7.
3. Weisblum B, Demohn V. Erythromycin-inducible resistance in Staphylococcus aureus: survey of antibiotic classes involved. J Bacteriol 1969 98 : 447 52.
4. Huygens F, Inman-Bamber J, Nimmo G, Munckhof W, Schooneveldt J, Harrison B et al. Staphylococcus aureus genotyping using novel real-time PCR formats. J Clin Microbiol 2006 44 : 3712 19.
5. Ahmed A, Jafri H, Lutsar I, McCoig CC, Trujillo M, Wubbel SS et al. Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1999 43 : 876 81.
6. Myrianthefs P, Markantonis SL, Vlachos K, Anagnostaki M, Boutzouka E, Panidis D et al. Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients. Antimicrob Agents Chemother 2006 50 : 3971 6.
7. Ebright JR, Pace MT, Niazi AF. Septic thrombosis of the cavernous sinuses. Arch Intern Med 2001 161 : 2671 6.
8. DiNubile MJ. Septic thrombosis of the cavernous sinuses. Arch Neurol 1988 45 : 567 72.
9. Tunkel AR. Subdural empyema, epidural abscess and suppurative intracranial thrombophlebitis. In : Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's Principles and Practices of Infectious Diseases, 6th edn. Philadelphia, PA : Elsevier Churchill Livingstone 2005 1164 71.
10. Cantoni L, Wenger A, Glauser MP, Bille J. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats. J Infect Dis 1989 159 : 989 93.
11. Munckhof WJ, Schooneveldt J, Coombs GW, Hoare J, Nimmo GR. Emergence of community-acquired methicillin-resistant Staphylococcus aureus infection in Queensland, Australia. Int J Infect Dis 2003 7 : 259 67.
12. Nimmo GR, Coombs GW, Pearson PC, O'Brien FG, Christiansen KJ, Tumidge JD et al. MRSA in the Australian community: an evolving epidemic. Med J Aust 2006 184 : 384 8.
13. Gonzalez B, Teruya J, Mahoney D, Hulten KG, Edwards R, Lamberth LB et al. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics 2006 117 : 1673 9.
14. Nourse C, Starr M, Munckhof WJ. Community-acquired methicillin resistant Staphylococcus aureus causes severe disseminated infection and deep venous thrombosis in children: literature review and recommendations for management. J Paediatr Child Health 2007 43 : 656 61.
15. Rutar T, Zwick OM, Cockerham KP, Horton JC. Bilateral blindness from orbital cellulitis caused by community-acquired methicillin-resistant Staphylococcus aureus. Am J Ophthalmol 2005 140 : 740 42.
16. Ross GH, Wright DH, Rotschafer JC, Ibrahim KH. Glycopeptide pharmacodynamics. In : Nightingale CH, Murakawa T, Ambrose PG, eds. Antimicrobial Pharmacodynamics in Theory and Clinical Practice, 1st edn. New York : Marcel Dekker 2002 177 204.
17. Rello J, Sole-Violan J, Sa-Borges M, Garnache-Montero J, Munoz E, Sirgo G et al. Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides. Crit Care Med 2005 33 : 1983 7.
18. Dudley MN, Levitz RE, Quintiliani R, Hickingbotham JM, Nightingale CH. Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid in adult patients with normal meninges. Antimicrob Agents Chemother 1984 26 : 811 14.
19. Nau R, Prange HW, Menck S, Kolenda H, Visser K, Seydel JK. Penetration of rifampicin into the cerebrospinal fluid of adults with uninflamed meninges. J Antimicrob Chemother 1992 29 : 719 24.
20. Therapeutic Guidelines Antibiotic. Version 13. North Melbourne, Victoria : Therapeutic Guidelines Ltd 2006.